Characterization of interior cleavage of retinoblastoma protein in apoptosis

Journal of Cellular Biochemistry

Volumn 67, Issue 3, 1997, Pages 399-408

  Fattman, Cheryl L ^a   An, Bing ^a   Dou, Q Ping ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase; CPP32; ICE; PARP; RB

Indexed keywords

CASPASE; ETOPOSIDE; PROTEIN ANTIBODY; RETINA S ANTIGEN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; DEPHOSPHORYLATION; DIAGNOSIS; ETIOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE; TUMOR SUPPRESSOR GENE;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASPARAGINE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL NUCLEUS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOPLASM; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ETOPOSIDE; HL-60 CELLS; HUMANS; JURKAT CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 0030670244     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971201)67:3<399::AID-JCB11>3.0.CO;2-8     Document Type: Article

References (35)

1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J (1996): Human ICE/ CED3 protease nomenclature. Cell 87:171.
2. An B, Dou QP (1996): Cleavage of retinoblastoma protein during apoptosis: An interleukin 1β-converting enzyme-like protease as candidate. Cancer Res 56:438-442.
3. An B, Jin J-R, Lin P, Dou QP (1996): Failure to activate interleukin-1β-converting enzyme-like protease and to cleave retinoblastoma protein in drug-resistant cells. FEBS Lett 399:153-162.
4. Chen W-D, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB, Kaye FJ (1997): Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene 14: 1243-1248.
5. Dignam JD, Lebovitz RM, Roeder RG (1993): Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
6. Dou QP (1997): Putative roles of retinoblastoma protein in apoptosis. Apoptosis 2:5-18.
7. Dou QP, An B, Will PL (1995): Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent GI arrest and apoptosis. Proc Natl Acad Sci USA 92:9019-9023.
8. Dou QP, An B, Antoku K, Johnson DE (1997): Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family. J Cell Biochem 64:586-594.
9. Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He W, Dixit VM ( 1996): ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem 271:35013-35035.
10. Hu Q, Bautista C, Edwards GM, Defeo-Jones D, Jones RE, Harlow E (1991): Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol 11:5792-5799.
11. Janicke RU, Walker PA, Lin XY, Porter AG (1996): Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 15:6969-6978.
12. Kaelin WG, Pallas DC, DeCaprio JA, Kaye FJ, Livingston DM (1991): Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521-532.
13. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993): Specific proteolytic cleavage of poly-(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976-3985.
14. Ludlow JW, DeCaprio JA, Huang C-M, Lee W-H, Paucha E, Livingston DM (1989): SV40 large T antigen binds preferentially to the underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:57-65.
15. Martin SJ, Newmeyer DD, Mathias S, Farschon DM, Wang H, Reed JC, Kolesnick RN, Green DR (1995): Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J 14:1591-5200.
16. Martins LM, Kottke T, Mesner PW, Basi GS, Sinha S, Frigon N Jr, Tatar E, Tung JS, Bryant K, Takahashi A, Svingen PA, Madden BJ, McCormick DJ, Earnshaw WC, Kaufmann SH (1997): Activation of multiple interleukin-1β-converting enzyme homologues in cytosol and nuclei of HL-60 cell during etoposide-induced apoptosis. J Biol Chem 272:7421-7430.
17. Mittnacht A, Weinberg RA (1991): G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381-393.
18. Morana SJ, Wolf CM, Li J, Reynolds JE, Brown MK, Eastman A (1996): The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion and apoptosis. J Biol Chem 271:18263-18271.
19. Nevins JR (1992): E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-428.
20. Nicholson DW, Ali A, Thornberry NA, Valliancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T, Yu VL, and Miller DK (1995): Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
21. Patel T, Gores GJ, Kaufmann SH (1996): The role of proteases during apoptosis. FASEB J 10:587-597.
22. Qin X-Q, Chittenden T, Livingston DM, Kaelin WG (1992): Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6:953-964.
23. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ (1992): Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β-converting enzyme. Cell 69:579-604.
24. Steller H (1995): Mechanism and genes of cellular suicide. Science 267:1445-1449.
25. Tan X, Martin SJ, Green DR, Wang JYJ (1997): Degradation of retinoblastoma protein in tumor necrosis factor-and CD95-induced cell death. J Biol Chem 272:9613-9616.
26. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM (1995): Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801-809.
27. Thompson CB (1995): Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
28. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin T, Lee TD, Shivery JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ (1992): A novel heterodimeric cy steine protease is required for interleukin-1β processing in monocytes. Nature 356:768-774.
29. Wang H, Grand RJA, Milner AE, Armitage RJ, Gordon J, Gregory CD (1996): Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: Relationship to the cell cycle and role of the retinoblastoma protein. Oncogene 13:373-379.
30. Wang JYJ, Knudsen ES, Welch PJ (1994): The retinoblastoma tumor suppressor protein. Adv Cancer Res 64:25-85.
31. Weinberg RA (1995): The retinoblastoma protein and cell cycle control. Cell 81:323-330.
32. Weinberg RA (1996): E2F and cell proliferation: A world turned upside down. Cell 85:457-459.
33. White E (1996): Life, death, and the pursuit of apoptosis. Genes Dev 10:1-15.
34. Williams GT, Smith CA (1993): Molecular regulation of apoptosis: Genetic controls on cell death. Cell 74:777-779.
35. Wylie AH, Kerr JFR, Currie AR (1980): Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.